Viewing Study NCT03834961

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:43 PM
Ignite Modification Date: 2026-01-27 @ 3:23 AM
Study NCT ID: NCT03834961
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2019-01-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
Sponsor: Children's Oncology Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Central Nervous System Neoplasm View
None Infantile Fibrosarcoma View
None Recurrent Acute Leukemia View
None Refractory Acute Leukemia View
None Solid Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Larotrectinib View
None TRK fusion View
None NTRK fusion View
None Infantile fibrosarcoma View